Coronavirus

Read the latest statement from CW's CEO

News

News and updates from our global community

Show filters

  • TTP plc collaborates with SOLshare to develop next generation solar energy trading platform

    TTP plc (TTP), a leading independent technology and product development company, has today announced it has entered into a partnership with ME SOLshare Ltd (‘SOLshare’), a social enterprise that has created a new approach to distributing and trading affordable solar electricity across peer-to-peer micro-grids. By making improvements to the SOLbox trading platform, the collaboration aims to increase the supply of sustainable electrical power to communities in developing countries.

    added by TTP plc 2 min Read
  • TTP plc, NHS Highland and The University of the Highlands and Islands to partner on atrial fibrillation clinical data collection and analysis project

    TTP plc (TTP), a leading independent technology and product development company, today announced it has established a partnership with NHS Highland and The University of the Highlands and Islands, to use clinical data interpretation and machine learning algorithms to predict which patients with atrial fibrillation (AF) are able to be successfully treated using electrical cardioversion (ECV).

    added by TTP plc 2 min Read
  • CW Member TTP plc enters into exclusive licence agreement with DiaSorin to commercialise molecular diagnostics platform

    TTP’s Puckdx platform offers a flexible and low-cost solution for translating sample-to-answer assays to a simple, easy-to-use desktop device for a range of diagnostic applications in human and animal health DiaSorin will utilise TTP’s Puckdx platform for human in vitro diagnostic assays Cambridge, UK, and Saluggia, Italy, 02 March 2020: TTP plc (TTP), a leading independent technology and product development company, and DiaSorin, a global leader in the in vitro diagnostic (IVD) field, have signed an exclusive licence and technology transfer agreement. DiaSorin will combine its extensive molecular test offering with TTP’s Puckdx™ platform to develop a single-use, sample-to-answer, molecular diagnostics point-of-care platform for human IVD applications.

    added by TTP plc 2 min Read
  • CW member TTP devise a route to low-cost RNA detection

    TTP plc (TTP), a leading independent technology and product development company, has successfully demonstrated a reverse transcriptase-free RNA detection method. The approach can be used with a standard qPCR master mix and a universal hydrolysis probe to produce concentration-dependent qPCR data without the need for a reverse transcriptase.

    added by TTP plc 1 min Read
  • CW member TTP inspires the next generation of scientists and engineers

    TTP plc continues to inspire Cambridge LaunchPad Scholar students into STEM. The company, based on Melbourn Science Park, is supporting Cambridge LaunchPad for the second year running as Founding Partner. The aim of the STEM outreach initiative is to broaden the appeal of STEM subjects and careers for young people of all backgrounds and genders. 

    added by TTP plc 2 min Read
  • TTP Group celebrated 30 years of innovation and product development with a party weekend in London

    Melbourn based technology company TTP Group celebrated 30 years of innovation and product development with a party weekend in London for the staff and their partners.

    added by TTP plc 1 min Read
  • TTP brings robotics to the next generation of coders

    The Technology Partnership funds new robotics lessons to teach coding to teachers and students alike

    added by TTP plc 3 min Read

Subscribe to the CW newsletter

This site uses cookies.

We use cookies to help us to improve our site and they enable us to deliver the best possible service and customer experience. By clicking accept or continuing to use this site you are agreeing to our cookies policy. Learn more

Start typing and press enter or the magnifying glass to search

Sign up to our newsletter
Stay in touch with CW

Choosing to join an existing organisation means that you'll need to be approved before your registration is complete. You'll be notified by email when your request has been accepted.

i
Your password must be at least 8 characters long and contain at least 1 uppercase character, 1 lowercase character and at least 1 number.

I would like to subscribe to

Select at least one option*